• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES, PR FOGARTY ARTERIAL EMBOLECTOMY CATHETER; CATHETER, EMBOLECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES, PR FOGARTY ARTERIAL EMBOLECTOMY CATHETER; CATHETER, EMBOLECTOMY Back to Search Results
Model Number 12TLW805F35
Device Problem Material Rupture (1546)
Patient Problem Insufficient Information (4580)
Event Type  malfunction  
Manufacturer Narrative
Patient demographics unable to be obtained.The lot number for this device was not supplied; therefore, further review of the related manufacturing records could not be performed.One fogarty catheter was received by our product evaluation laboratory for a full examination.Examination of the returned catheter found that the balloon was found to be ruptured in the middle area.Rupture edges did not appear to match up.Per the ifu "balloon rupture and catheter separation as a result of excessive pull force applied to remove adherent material are the most frequent causes of reported failures." and "to minimize the risk of vessel damage, balloon rupture, or tip detachment, do not exceed the maximum recommended inflation and pull force for each size catheter.See specification table".Through lumen was patent without any leakage or occlusion.No other visible damage or abnormality was observed from catheter body or windings.An engineering investigation will be performed in order to consider any potential factors that may have contributed to this complaint.A supplemental report will be submitted accordingly upon investigation completion.
 
Event Description
A fogarty catheter from model nr.12tlw805f35 was received by our evaluation laboratory.As per visual inspection upon receipt the balloon seems to be damaged.No more information available.
 
Manufacturer Narrative
Added information to section h6 (type of investigation) updated section h6 (investigation findings) and h6 (investigations conclusions).Based on further engineering investigation, as part of the manufacturing process, the units go through a balloon inspection process including visual inspection in which the integrity of the catheter and balloon are validated.Also, a final inspection is performed.Additionally, as per specification for catheters produced by edwards lifesciences it is specified that the deterioration is a condition usually caused by age, excessive exposure to light, atmosphere, or ozone that appears on the balloon surface as a maze of fine cracks or crazing.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FOGARTY ARTERIAL EMBOLECTOMY CATHETER
Type of Device
CATHETER, EMBOLECTOMY
Manufacturer (Section D)
EDWARDS LIFESCIENCES, PR
state rd indus pk 402 km 1.4
anasco PR 00610
Manufacturer (Section G)
EDWARDS LIFESCIENCES, PR
state rd indus pk 402 km 1.4
anasco PR 00610
Manufacturer Contact
samantha eveleigh
1 edwards way
irvine, CA 92614
9492503939
MDR Report Key17264988
MDR Text Key318551539
Report Number2015691-2023-14363
Device Sequence Number1
Product Code DXE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K193379
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model Number12TLW805F35
Device Catalogue Number12TLW805F35
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/29/2023
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/13/2023
Initial Date FDA Received07/06/2023
Supplement Dates Manufacturer Received09/05/2023
Supplement Dates FDA Received09/11/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-